Navigantis Inc. announced today the first successful neurovascular clinical cases performed with its VASCO interventional robotic platform for patients suffering from neurovascular disorders.

at 09:00 NAVIGANTIS VASCOtm Robotic Platform Used with First Patients Enrolled in Neurovascular Study Navigantis Inc. announced today the first successful neurovascular clinical cases performed with ...

MIAMI, Dec. 27, 2024 /PRNewswire/ -- Navigantis Inc. announced today the first successful neurovascular clinical cases performed with its VASCO interventional robotic platform for patients suffering ...

Stryker Corporation's growth strategy includes acquisitions, but high debt levels and goodwill present challenges, making ...

Balt, a global medical device leader in interventional neuroradiology, announces that it has secured €355 million in ...

These three dividend-paying Dow stocks dominate the health care sector and look like incredible values now for growth and ...

The National Institute of Neurological Disorders and Stroke has awarded $2.18 million to two researchers at the University of ...

Like a complex network of highways, retinal microcirculation is a hidden system that powers the life of the eye—delivering ...

Dr. Babajide Ogunseinde, a orthopedic spine surgeon with Longview Orthopedics Regional Clinics, designed a unique technique to treat sacroiliac joint dysfunction.

Retinal microcirculation and hemodynamics provide valuable information on neurovascular diseases, as many diseases of the ...

Fluid Biomed has raised $27 million to move forward with the development of its bioabsorbable stent designed to divert blood ...